Evidence map›Paper›PMID 28038331›Full record

ReviewCurrent opinion in structural biology2017

Protein unfolding under isometric tension-what force can integrins generate, and can it unfold FNIII domains?

Harold P Erickson

Abstract readReview
In one paragraph

Review in Current opinion in structural biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Fibronectin matrix assembly at a glance.Journal of cell science · 2025
    Review
  2. Shaping Oncogenic Microenvironments: Contribution of Fibronectin.Frontiers in cell and developmental biology · 2024
    Review
  3. Review
  4. Article
  5. Article
  6. Molecular Tension Sensors: Moving Beyond Force.Current opinion in biomedical engineering · 2019
    Article
  7. Article
  8. Heparin-fibronectin interactions in the development of extracellular matrix insolubility.Matrix biology : journal of the International Society for Matrix Biology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Harold P EricksonDepartment of Cell Biology, Duke University Medical Center, Durham, NC 27710, USA. Electronic address: h.erickson@cellbio.duke.edu.

Funding

EXTRACELLULAR MATRIX AND CELL ATTACHMENT PROTEINSR01CA047056 · NCI · DUKE UNIVERSITY · PI ERICKSON, HAROLD P · 1988 to 2016
$4.7M
EXTRACELLULAR MATRIX AND CELL ATTACHMENT PROTEINSR37CA047056 · NCI · DUKE UNIVERSITY · PI ERICKSON, HAROLD P · 1993 to 2000
$308k
NCI NIH HHS R01 CA047056NCI NIH HHS R37 CA047056
6 · The paper itself

Abstract

Extracellular matrix fibrils of fibronectin (FN) are highly elastic, and are typically stretched three to four times their relaxed length. The mechanism of stretching has been controversial, in particular whether it involves tension-induced unfolding of FNIII domains. Recent studies have found that ∼5pN is the threshold isometric force for unfolding various protein domains. FNIII domains should therefore not be unfolded until the tension approaches 5pN. Integrins have been reported to generate forces ranging from 1 to >50pN, but I argue that studies reporting 1-2pN are the most convincing. This is not enough to unfold FNIII domains. Even if domains were unfolded, 2pN would only extend the worm-like-chain to about twice the length of the folded domain. Overall I conclude that stretching FN matrix fibrils involves primarily the compact to extended conformational change of FN dimers, with minimal contribution from unfolding FNIII domains.

Indexed as

Mechanical PhenomenaProtein UnfoldingFibronectinsIntegrinsProtein DomainsProtein RefoldingFibronectinsIntegrins

Identifiers

PMID28038331
PMCPMC5374013

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.